BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27363059)

  • 1. MAGGOT DEBRIDEMENT THERAPY (MDT): IT IS SAFE AND ECONOMIC FOR TREATING A DIABETIC FOOT ULCER.
    El-Tawdy AH; Ibrahim EA; Abdallah ES; Al Sakhawy EM; Morsy TA
    J Egypt Soc Parasitol; 2016 Apr; 46(1):223-34. PubMed ID: 27363059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of maggot debridement therapy in promoting wound angiogenesis in patients with diabetic foot ulcer].
    Wang TY; Chen YC; Wang W; Jiang D; Liu L; Yang H; Wang AP
    Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1040-1049. PubMed ID: 33238687
    [No Abstract]   [Full Text] [Related]  

  • 3. Maggot debridement therapy: a systematic review.
    Shi E; Shofler D
    Br J Community Nurs; 2014 Dec; Suppl Wound Care():S6-13. PubMed ID: 25478859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of Maggot Debridement Therapy for Chronic Wounds: A Bibliographic Review.
    Moya-López J; Costela-Ruiz V; García-Recio E; Sherman RA; De Luna-Bertos E
    Adv Skin Wound Care; 2020 Oct; 33(10):515-525. PubMed ID: 32941225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy.
    Zhang J; Sun XJ; Chen J; Hu ZW; Wang L; Gu DM; Wang AP
    J Diabetes Complications; 2017 Jan; 31(1):241-244. PubMed ID: 27623390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maggot treatment promotes healing of diabetic foot ulcer wounds possibly by upregulating Treg levels.
    Zhang J; Chen J; Gao C; Sun X; Wang L; Hu Z; Li G; Wang J; Wang A
    Diabetes Res Clin Pract; 2022 Feb; 184():109187. PubMed ID: 35016990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
    Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
    J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining pain levels in patients treated with maggot debridement therapy.
    Steenvoorde P; Budding T; Oskam J
    J Wound Care; 2005 Nov; 14(10):485-8. PubMed ID: 16304925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of medical-grade maggots in facilitating healing of diabetic foot ulcers in Kano, northern Nigeria: a case series.
    Yusuf MA; Ibrahim BM; Abubakar F; Ibrahim M; Sheshe AA; Abubakar MK; Aji SA; Gbadamasi KA; Busayo JK; Sallau SB; Ridwan BA; Uloko AE; Gezawa ID; Ramalan M; Sidi K; Abdullahi S; Adamu KM; Bello N; Muhammad A; Mukhtar R; Aina D
    J Wound Care; 2024 Feb; 33(Sup2):S24-S30. PubMed ID: 38348863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
    Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
    Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maggot excretions/secretions promote diabetic wound angiogenesis via miR18a/19a - TSP-1 axis.
    Wang TY; Wang W; Li FF; Chen YC; Jiang D; Chen YD; Yang H; Liu L; Lu M; Sun JS; Gu DM; Wang J; Wang AP
    Diabetes Res Clin Pract; 2020 Jul; 165():108140. PubMed ID: 32277954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study.
    Siavash M; Najjarnezhad A; Mohseni N; Abtahi SM; Karimy A; Sabzevari MH
    Int J Low Extrem Wounds; 2021 Dec; 20(4):315-320. PubMed ID: 32370633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maggot debridement therapy and complementary wound care: a case series from Nigeria.
    Yusuf MA; Ibrahim BM; Oyebanji AA; Abubakar F; Ibrahim M; Ibrahim Jalo R; Aminu A; Akbarzadeh K; Azam M; Sheshe AA; Ganiyu OO; Abubakar MK; Salisu WJ; Kordshouli RS; Adamu AY; Takalmawa H; Daneji I; Aliyu M; Ibrahim MG; Kabuga AI; Abdullahi AS; Abbas MA
    J Wound Care; 2022 Nov; 31(11):996-1005. PubMed ID: 36367805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maggot debridement therapy to treat hard-to-heal diabetic foot ulcers: a single-centre study.
    Nair HK; Ahmad NW; Ismail AA; Alabed AAA; Zheming BO; Kaur G; Hassan H; Supaat NI
    J Wound Care; 2021 Dec; 30(Sup12):S30-S36. PubMed ID: 34882006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers.
    Shamloul G; Khachemoune A
    Int J Dermatol; 2023 Jul; 62(7):962-968. PubMed ID: 36880424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maggot debridement therapy promotes diabetic foot wound healing by up-regulating endothelial cell activity.
    Sun X; Chen J; Zhang J; Wang W; Sun J; Wang A
    J Diabetes Complications; 2016 Mar; 30(2):318-22. PubMed ID: 26782021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.
    Sherman RA
    Diabetes Care; 2003 Feb; 26(2):446-51. PubMed ID: 12547878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, quality improvement review of maggot debridement therapy outcomes in a foot and leg ulcer clinic.
    Campbell N; Campbell D
    Ostomy Wound Manage; 2014 Jul; 60(7):16-25. PubMed ID: 25019246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.